According to Future Market Insights, the Chronic Pulmonary Hypertension Treatment Market revenue will reach US$ 7 billion in 2023 and is expected to reach US$ 11.4 billion by 2033, growing at a CAGR of 5% from 2023 to 2033. The rising prevalence of pulmonary hypertension and the increasing availability of effective treatment options are expected …